Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
28 studies found for:    " December 12, 2007":" January 11, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Motivational interviewing with cognitive behavioral therapy;   Behavioral: Modified directly observed therapy
2 Completed Role of Positive Affect in Adjustment to HIV
Condition: HIV Infections
Intervention:
3 Unknown  Pharmacotherapy for HIV+ Stimulant Dependent Individuals
Conditions: HIV Infections;   Cocaine Dependence
Intervention: Drug: ondansetron
4 Completed HIV Resistance and Treatment Strategies
Condition: HIV Infections
Intervention:
5 Completed Family-Based HIV Prevention for Latinos
Condition: HIV Infections
Interventions: Behavioral: Family-Based HIV Prevention for Latinos;   Behavioral: General Health Promotion
6 Completed Evaluation of Opt-Out Rapid HIV Testing in the Emergency Department
Condition: HIV Infections
Intervention: Other: Non-targeted opt-out rapid HIV screening
7 Completed Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Lopinavir / ritonavir;   Drug: Lopinavir/ritonavir
8 Completed HIV Non Occupational Post-Exposure Prophylaxis (PEP)
Condition: HIV Infections
Intervention: Drug: Fixed-dose Formulation of Tenofovir and Raletgravir
9 Completed Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults
Condition: HIV Infections
Interventions: Biological: SAAVI DNA-C2 vaccine;   Biological: SAAVI MVA-C vaccine;   Biological: Placebo
10 Completed
Has Results
Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: Pegylated Interferon-alpha 2a, 180 mcg/week sc;   Drug: Pegylated Interferon-alpha 2a, 90 mcg/week sc
11 Completed HIV-HCV Coinfection: Impact of Immune Dysfunction
Conditions: HIV Infections;   Hepatitis
Intervention:
12 Unknown  Energy Specific Far Infrared Radiation Treatment for AIDS
Condition: HIV Infections
Intervention: Radiation: Far infrared
13 Completed
Has Results
Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix TM) in HIV Infected Females
Conditions: HPV-16/18 Infections;   Cervical Neoplasia
Interventions: Biological: Cervarix TM;   Biological: Placebo Control
14 Completed Understanding the Increased Risk of Cardiovascular Disease in People With HIV
Condition: HIV Infections
Intervention: Drug: Antiretroviral Therapy (ART)
15 Completed CNS (Central Nervous System) Viral Dynamics and Cellular Immunity During AIDS
Condition: HIV Infections
Intervention:
16 Completed Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV
Conditions: HIV Infections;   Atherosclerosis
Intervention:
17 Completed Family Access to Care Study (FACS)
Condition: HIV Infections
Intervention:
18 Completed Relationship Between HIV-1 Subtype and ARV Response
Condition: HIV Infections
Intervention: Drug: NRTI/NNRTI/ Kaletra
19 Completed Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women
Condition: HIV Infections
Interventions: Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir gel
20 Completed Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women
Condition: HIV Infections
Interventions: Drug: Tenofovir gel;   Drug: Tenofovir gel placebo

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years